Request Deal Involvement

RA Capital led a $98m Series C round in Kinnate Biopharma.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Principals

KINNATE BIOPHARMA

target

KINNATE BIOPHARMA

NEXTECH INVEST

bidder

NEXTECH INVEST

RA CAPITAL MANAGEMENT

bidder

RA CAPITAL MANAGEMENT

ORBIMED ADVISORS LLC

bidder

ORBIMED ADVISORS LLC

FIDELITY MANAGEMENT & RESEARCH COMPANY

bidder

FIDELITY MANAGEMENT & RESEARCH COMPANY

VIKING GLOBAL INVESTORS

bidder

VIKING GLOBAL INVESTORS

VIDA VENTURES

bidder

VIDA VENTURES

VENROCK

bidder

VENROCK

FORESITE CAPITAL MANAGEMENT LLC

bidder

FORESITE CAPITAL MANAGEMENT LLC

JANUS HENDERSON INVESTORS

bidder

JANUS HENDERSON INVESTORS

SURVEYOR CAPITAL

bidder

SURVEYOR CAPITAL

BOXER CAPITAL

bidder

BOXER CAPITAL

LOGOS CAPITAL

bidder

LOGOS CAPITAL

SVB LEERINK

bidder

SVB LEERINK

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite